Liquidia Corp. (LQDA)
54.43
-2.20
(-3.88%)
USD |
NASDAQ |
Nov 20, 16:00
54.28
-0.15
(-0.28%)
After-Hours: 20:00
Liquidia Research and Development Expense (TTM) : 70.90M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 70.90M |
| June 30, 2026 | 54.95M |
| March 31, 2026 | 44.01M |
| December 31, 2025 | 38.35M |
| September 30, 2025 | 37.78M |
| June 30, 2025 | 40.29M |
| March 31, 2025 | 43.49M |
| December 31, 2024 | 46.64M |
| September 30, 2024 | 43.04M |
| June 30, 2024 | 38.60M |
| March 31, 2024 | 46.85M |
| December 31, 2023 | 42.06M |
| September 30, 2023 | 33.93M |
| June 30, 2023 | 30.90M |
| March 31, 2023 | 18.33M |
| December 31, 2022 | 17.68M |
| September 30, 2022 | 18.20M |
| June 30, 2022 | 18.15M |
| Date | Value |
|---|---|
| March 31, 2022 | 17.50M |
| December 31, 2021 | 18.70M |
| September 30, 2021 | 18.33M |
| June 30, 2021 | 21.21M |
| March 31, 2021 | 24.81M |
| December 31, 2020 | 29.33M |
| September 30, 2020 | 32.17M |
| June 30, 2020 | 35.50M |
| March 31, 2020 | 37.84M |
| December 31, 2019 | 37.85M |
| September 30, 2019 | 38.43M |
| June 30, 2019 | 35.32M |
| March 31, 2019 | 31.13M |
| December 31, 2018 | 28.70M |
| September 30, 2018 | 27.49M |
| June 30, 2018 | 26.86M |
| March 31, 2018 | 26.20M |
| December 31, 2017 | 24.75M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| United Therapeutics Corp. | 703.20M |
| Eli Lilly & Co. | 15.38B |
| Mentari Therapeutics, Inc. | 2.665M |
| Corcept Therapeutics, Inc. | 241.72M |
| Johnson & Johnson | 16.02B |